| Andrew David Biekert, PHARM D | |
|
1617 Manufacturers Dr, Fenton, MO 63026-2838 | |
| (314) 690-4500 | |
| Not Available |
| Full Name | Andrew David Biekert |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1617 Manufacturers Dr, Fenton, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265958219 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 019495 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Andrew David Biekert, PHARM D 1344 Briar Path Ct, Columbia, IL 62236-2752 Ph: (618) 977-5090 | Andrew David Biekert, PHARM D 1617 Manufacturers Dr, Fenton, MO 63026-2838 Ph: (314) 690-4500 |
News Archive
Researchers at UC San Francisco and UC Berkeley have teamed up to create an innovative, integrated center for research on neurodegenerative diseases. Supported by a $3 million grant from the Glenn Foundation for Medical Research, the new center aims to pave the way to developing novel treatments for diseases such as Alzheimer's disease and Parkinson's disease by investigating the many ways that proteins can malfunction within cells.
A new study found significant changes in white matter pathways in the brains of individuals with autism spectrum disorder (ASD) using a novel technique called Automated Fiber Quantification (AFQ).
Coloplast announced today that it has acquired Mpathy Medical, a fast growing company in women's health, for a total cash consideration of USD 30m equal to DKK162m, potentially increasing to a total of USD 35m equal to DKK 189m on a cash and debt free basis. The acquisition expands the Coloplast female health portfolio of innovative product technologies and surgical solutions for female stress urinary incontinence and pelvic organ prolapse.
Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has entered into an agreement with GeneNews (TSX: GEN), of Toronto, Canada, for exclusive rights to market GeneNews' ColonSentry™, a proprietary blood test for colorectal cancer, in the states of New York and New Jersey.
› Verified 8 days ago
Mr. Robert C Suhovecky, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1210 Sugar Creek Sq, Fenton, MO 63026 Phone: 636-326-5113 | |
Brian James Voss, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 512 Deer Pointe Ct, Fenton, MO 63026 Phone: 314-809-5111 | |
Mark Froidl, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 Bowles Ave, Fenton, MO 63026 Phone: 636-343-0754 | |
Dr. Sara K Rumpel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2058 Fenton Logistics Park, Fenton, MO 63026 Phone: 877-273-1777 | |
Mahdee Shawahin, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1210 Sugar Creek Sq, Fenton, MO 63026 Phone: 636-326-5113 | |
Dr. Erica Lynn Schaeffer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 701 Gravois Bluffs Blvd, Fenton, MO 63026 Phone: 636-343-8402 | |
Catherine Bundschuh, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 Bowles Ave, Fenton, MO 63026 Phone: 636-343-0754 |